Conference
PANCREOX: A randomized phase 3 study of 5FU/LV with or without oxaliplatin for second-line advanced pancreatic cancer (APC) in patients (pts) who have received gemcitabine (GEM)based chemotherapy (CT).
Authors
Gill S; Ko Y-J; Cripps MC; Beaudoin A; Dhesy-Thind SK; Zulfiqar M; Zalewski P; Do T; Cano PO; Lam W
Volume
32
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
May 20, 2014
Name of conference
50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Conference place
IL, Chicago
Conference start date
May 30, 2014
Conference end date
June 3, 2014
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
15
ISSN
0732-183X